Aspartyl-tRNA Synthetase Is the Target of Peptide Nucleotide Antibiotic Microcin C*

Microcin C is a ribosome-synthesized heptapeptide that contains a modified adenosine monophosphate covalently attached to the C-terminal aspartate. Microcin C is a potent inhibitor of bacterial cell growth. Based on the in vivo kinetics of inhibition of macromolecular synthesis, Microcin C targets translation, through a mechanism that remained undefined. Here, we show that Microcin C is a subject of specific degradation inside the sensitive cell. The product of degradation, a modified aspartyl-adenylate containing an N-acylphosphoramidate linkage, strongly inhibits translation by blocking the function of aspartyl-tRNA synthetase.

[1]  J. Reader,et al.  Major Biocontrol of Plant Tumors Targets tRNA Synthetase , 2005, Science.

[2]  G. Montelione,et al.  Structure of antibacterial peptide microcin J25: a 21-residue lariat protoknot. , 2003, Journal of the American Chemical Society.

[3]  M. Sekine,et al.  Synthesis and properties of aminoacylamido-AMP: chemical optimization for the construction of an N-acyl phosphoramidate linkage. , 2000, The Journal of organic chemistry.

[4]  S. Sablé,et al.  New developments in non-post translationally modified microcins. , 2002, Biochimie.

[5]  V. Braun,et al.  Ton-dependent colicins and microcins: modular design and evolution. , 2002, Biochimie.

[6]  V. Braun,et al.  Intracellular activation of albomycin in Escherichia coli and Salmonella typhimurium , 1983, Journal of bacteriology.

[7]  A. Shashkov,et al.  Structure of microcin C51, a new antibiotic with a broad spectrum of activity , 1995, FEBS letters.

[8]  J. L. San Millán,et al.  Structure and organization of plasmid genes required to produce the translation inhibitor microcin C7 , 1995, Journal of bacteriology.

[9]  Jeffrey H. Miller.  Experiments in molecular genetics , 1972 .

[10]  E. V. Makeyev,et al.  Co-translational Folding of an Eukaryotic Multidomain Protein in a Prokaryotic Translation System* , 2000, The Journal of Biological Chemistry.

[11]  Ulf Göransson,et al.  Microcin J25 has a threaded sidechain-to-backbone ring structure and not a head-to-tail cyclized backbone. , 2003, Journal of the American Chemical Society.

[12]  R. Chěnevert,et al.  Synthesis and aminoacyl-tRNA synthetase inhibitory activity of aspartyl adenylate analogs. , 2005, Bioorganic & medicinal chemistry.

[13]  S. Rebuffat,et al.  Focus on modified microcins: structural features and mechanisms of action. , 2002, Biochimie.

[14]  R. Kolter,et al.  From Peptide Precursors to Oxazole and Thiazole-Containing Peptide Antibiotics: Microcin B17 Synthase , 1996, Science.

[15]  B. Chait,et al.  Structure of microcin J25, a peptide inhibitor of bacterial RNA polymerase, is a lassoed tail. , 2003, Journal of the American Chemical Society.

[16]  M. Delepierre,et al.  Chemical Structure and Translation Inhibition Studies of the Antibiotic Microcin C7 (*) , 1995, The Journal of Biological Chemistry.

[17]  A. Maxwell,et al.  Evidence for the role of DNA strand passage in the mechanism of action of microcin B17 on DNA gyrase. , 2005, Biochemistry.

[18]  G. Zubay,et al.  In vitro synthesis of protein in microbial systems. , 1973, Annual review of genetics.

[19]  D. Söll,et al.  Cysteine Activation Is an Inherent in Vitro Property of Prolyl-tRNA Synthetases* , 2002, The Journal of Biological Chemistry.

[20]  D. Söll,et al.  Glutamyl-tRNA(Gln) amidotransferase in Deinococcus radiodurans may be confined to asparagine biosynthesis. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[21]  J. González-Pastor,et al.  The regulation of microcin B, C and J operons. , 2002, Biochimie.

[22]  J. McCloskey,et al.  Structure of the antifungal nucleotide antibiotic phosmidosine , 1993 .

[23]  Jennifer L. Knight,et al.  Antibacterial peptide microcin J25 inhibits transcription by binding within and obstructing the RNA polymerase secondary channel. , 2004, Molecular cell.

[24]  A. Fersht,et al.  Site-directed mutagenesis as a probe of enzyme structure and catalysis: tyrosyl-tRNA synthetase cysteine-35 to glycine-35 mutation. , 1983, Biochemistry.

[25]  D. Fomenko,et al.  Microcin C51 Plasmid Genes: Possible Source of Horizontal Gene Transfer , 2003, Antimicrobial Agents and Chemotherapy.

[26]  G. Eriani,et al.  The structure of an AspRS—tRNAAsp complex reveals a tRNA‐dependent control mechanism , 2001, The EMBO journal.

[27]  A. Spirin,et al.  Effective non-viral leader for cap-independent translation in a eukaryotic cell-free system. , 2004, Biotechnology and bioengineering.